Skip to main content
Premium Trial:

Request an Annual Quote

Senate Considering Personalized Medicine in Budget

NEW YORK (GenomeWeb News) – The Senate will consider an amendment to the 2010 budget that would promote the use of personalized medicine in comparative effectiveness research and would prohibit Federal health care programs from using data from such research to deny coverage for treatments and services.

The Senate version of the 2010 budget resolution includes a section that was in President Barack Obama's budget that called for using money from a healthcare fund in the bill to support comparative effectiveness research "that can drive evidence-based medicine and build a rapidly-learning health care system."

Senator John Kyl (R – Ariz.) today introduced language to the bill that would amend it to ensure that comparative effectiveness research "accounts for advancements in genomics and personalized medicine, the unique needs of health disparity populations, and differences in the treatment response and the treatment preferences of patients."

The amendment also would tailor the bill so that it would "protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny coverage of items or services under Federal health care programs."

The amendment did not have a co-sponsor from the majority party, which led The Personalized Medicine Coalition's Public Policy Director Amy Miller to suggest that it may be unlikely to make it into the final budget.

PMC supports making decisions about coverage "based on sound science," Miller explained in an e-mail today, which means there must be "mechanisms for new evidence to be used to update [comparative effectiveness research] findings."

Although PMC lauds the move to include personalized medicine in comparative effectiveness, Miller said, it could not "fully" support the amendment due to the clause related to denial of coverage.

Senator Kyl was scheduled to speak about the issues on the Senate floor this afternoon.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.